These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2802597)

  • 21. Facile isolation of endo-pectate lyase from Erwinia carotovora based on electrostatic interaction.
    Fukuoka S; Kamishima H; Sode K; Karube I
    Appl Biochem Biotechnol; 1990 Dec; 26(3):239-48. PubMed ID: 2091529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and properties of L-asparaginase of Erwinia aroideae.
    Liu FS; Zajic JE
    Can J Microbiol; 1972 Dec; 18(12):1953-7. PubMed ID: 4649741
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification of L-asparaginase from a bacteria Erwinia carotovora and effect of a dihydropyrimidine derivative on some of its kinetic parameters.
    Kamble VP; Rao RS; Borkar PS; Khobragade CN; Dawane BS
    Indian J Biochem Biophys; 2006 Dec; 43(6):391-4. PubMed ID: 17285805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
    Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between the magnitude of Km and pH for L-asparaginase].
    Libinson GS; Mikhalev AV
    Biokhimiia; 1976 Jan; 41(1):149-52. PubMed ID: 6070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-asparaginase activity in cell-free extracts of Thermoactinomyces vulgaris 13 M.E.S.
    Mostafa SA; Ali OK
    Zentralbl Mikrobiol; 1983; 138(5):397-404. PubMed ID: 6649956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fermentation kinetics and continuous process of L-asparaginase production.
    Liu FS; Zajic JE
    Appl Microbiol; 1973 Jan; 25(1):92-6. PubMed ID: 4568894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a monoclonal antibody against active pectate lyase from Erwinia carotovora.
    Ward LJ; De Boer SH
    Can J Microbiol; 1989 Jun; 35(6):651-5. PubMed ID: 2766119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and partial purification of L-asparaginase from Corynebacterium glutamicum.
    Mesas JM; Gil JA; Martín JF
    J Gen Microbiol; 1990 Mar; 136(3):515-9. PubMed ID: 2391490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
    Uren JR; Hargis BJ; Beardsley P
    Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols.
    Vieira Pinheiro JP; Ahlke E; Nowak-Göttl U; Hempel G; Müller HJ; Lümkemann K; Schrappe M; Rath B; Fleischhack G; Mann G; Boos J
    Br J Haematol; 1999 Feb; 104(2):313-20. PubMed ID: 10050714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple method for the isolation and purification of L-asparaginase from Enterobacter aerogenes.
    Mukherjee J; Joeris K; Riechel P; Scheper T
    Folia Microbiol (Praha); 1999; 44(1):15-8. PubMed ID: 10489691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and properties of a membrane-bound L-asparaginase of Tetrahymena pyriformis.
    Triantafillou DJ; Georgatsos JG; Kyriakidis DA
    Mol Cell Biochem; 1988 May; 81(1):43-51. PubMed ID: 3139990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D; Neerhout RC; Bleyer A
    Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct process integration of cell disruption and fluidised bed adsorption in the recovery of labile microbial enzymes.
    Bierau H; Hinton RJ; Lyddiatt A
    Bioseparation; 2001; 10(1-3):73-85. PubMed ID: 11787801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic and immunodepressive effects of L-asparaginase from E. coli and from Erwinia carotovora following chronic administration in rats.
    Celle G; Dodero M; Cuneo P; Picciotto A; Brambilla G; Cavanna M; Pannaciulli I
    Arzneimittelforschung; 1977; 27(11):2046-50. PubMed ID: 341899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro blastogenesis inhibited by Erwinia carotovora L-asparaginase.
    Han T; Onuma T
    Nat New Biol; 1972 Sep; 239(89):50-1. PubMed ID: 4561972
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficient purification of recombinant human NDPK-A in pilot-scale].
    Xiong S; Qian CW; Guo CW; Huang L; Liu QY; Zhang MY; Wang YF
    Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):508-13. PubMed ID: 17578003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.
    Albertsen BK; Schrøder H; Jakobsen P; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Clin Pharmacol; 2001 Oct; 52(4):433-7. PubMed ID: 11678787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.